Matthew T Drake MD

PubMed

• Bone Health in Patients With Adrenal Adenomas and Hypercortisolism: A Multicenter Cross-Sectional Study.
  Prerna Dogra, Lana Šambula, Jasmine Saini, Matthew T Drake, Shobana Athimulam
  Clinical Endocrinology. 2026-02-01
• Bone anabolic therapy in breast cancer: is there a role for parathyroid hormone or parathyroid hormone-related protein?
  Hanna Taipaleenmäki, Matthew T Drake
  JBMR Plus. 2025-09-01
• 1 citations
  Gallium-68-DOTATATE PET/CT for phosphaturic mesenchymal tumor localization in suspected tumor-induced osteomalacia.
  Caroline W S Hoong, Jad G Sfeir, Matthew T Drake, Stephen M Broski
  JBMR Plus. 2025-05-01

Journal Articles

• Effects of suppression of follicle-stimulating hormone secretion on bone resorption markers in postmenopausal women  
  Drake MT, McCready LK, Hoey KA, Atkinson EJ, Khosla S, Obstet Gynecol Surv, 5/1/2011
• Corrigendum to "Circulating osteogenic cells: Characterization and relationship to rates of bone loss in postmenopausal women"  
  Undale A, Srinivasan B, Drake M, McCready L, Atkinson E, Peterson J, Riggs BL, Amin S, Modder UI, Khosla S, Bone, 1/1/2011
• Vitamin D deficiency in multiple myeloma  
  Drake MT, Ng AC, European journal of Clinical and Medical Oncology, 1/1/2010

Books/Book Chapters

• Multiple myeloma: diagnosed and treatment. 
  Chapter: Myeloma bone disease. 
  Page 211 - 223Drake MTEditors: Gertz MA; Rajkumar SV.Springer, New York, NY2014
• Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 
  Chapter: The Role of Sex Steroids in the Pathogenesis of Osteoporosis. 
  Page 367 - 375Drake MT, Khosla SEdition 8tj,2013
• Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 
  Chapter: Role of sex steroids in the pathogenesis of osteoporosis. 
  Page 208 - 213Drake MT, Khosla SEdition 7th,2009

Abstracts/Posters

• Controversies in Pharmaceutical Management of Osteoporosis Therapy
  Drake MT, American Association of Clinical Endocrinologists Annual Meeting, 5/1/2014
• Monoclonal Gammopathy Associated Bone Loss
  Drake MT, Dresden University Medical Center, Dresden, Germany, 4/1/2014
• Bone loss in monoclonal gammopathy of undetermined significance.
  Drake MT, Advances in Mineral Metabolism Annual Meeting, 4/1/2014

Lectures

• Monoclonal Gammopathy of Undetermined Significance (MGUS): Indications for Pre-Diagnostic Testing, Subsequent Diagnoses, and Follow-up Practice 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Optimizing Bone Health in Multiple Myeloma. 
  Atlanta, GA - 5/1/2014
• Monoclonal gammopathy-associated bone loss. 
  10/1/2013